RecruitingNot ApplicableNCT06989892
Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial
Sponsor
Navamindradhiraj University
Enrollment
202 participants
Start Date
Jul 25, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \> 50 pg/ml)
Exclusion Criteria2
- Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.
- Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.
Interventions
DEVICESuper High-flux dialyzer (Elisio 19HDx)
Dialysis with Super High-flux dialyzer for intervention group
DEVICEHigh-flux dialyzer (Elisio 19H)
Dialysis with High-flux dialyzer for control group
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06989892
Related Trials
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
NCT070599624 locations
Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients
NCT071573971 location
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT0568144228 locations
Safe and Explainable AI
NCT066941811 location
Evaluation of Pediatric eCART Implementation
NCT067718301 location